Skip to main content

Part of cannabis and investing

Health Canada says it is changing its process for issuing cannabis licenses in a bid to reduce wait times and better use the agency’s resources.

The Ottawa-based agency says new applicants for licences to cultivate, process or sell cannabis must now have a fully built site that meets regulations when they submit their application.

Prior to this, cannabis license applicants could submit an application with their plans and get approval before building.

Story continues below advertisement

The agency says a “significant” amount of resources has been used to review applications from entities that are not ready to begin operations, contributing to wait times for “more mature applications” and “an inefficient allocation of resources.”

Health Canada says over the past three years, more than 70 per cent of licensing applicants which passed its initial paper-based review have yet to submit the required evidence to demonstrate they have built a facility that meets the regulatory requirements.

The change comes as cannabis retailers across the country continue to face supply challenges, more than six months after Canada legalized pot for recreational use.

Available now: Cannabis Professional, the authoritative news service tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter